Rifampicin Resistance Associated with rpoB Mutations in Neisseria gonorrhoeae Clinical Strains Isolated in Austria, 2016 to 2020

Due to increasing rates of antimicrobial resistance (AMR) in Neisseria gonorrhoeae, alternative treatments should be considered. To assess rifampicin’s potential as a gonorrhea treatment, we used rpoB mutations to estimate rifampicin resistance in Austrian N. gonorrhoeae isolates. We found 30% of re...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaeffer, Justine, Lippert, Kathrin, Pleininger, Sonja, Stöger, Anna, Hasenberger, Petra, Stadlbauer, Silke, Heger, Florian, Eigentler, Angelika, Geusau, Alexandra, Indra, Alexander, Allerberger, Franz, Ruppitsch, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241671/
https://www.ncbi.nlm.nih.gov/pubmed/35678576
http://dx.doi.org/10.1128/spectrum.02757-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241671/
https://www.ncbi.nlm.nih.gov/pubmed/35678576
http://dx.doi.org/10.1128/spectrum.02757-21

Ejemplares similares